The role and clinical significance of pulmonary function tests

Pulmonary function testing is an important means of evaluating lung ventilation and ventilation function through a series of standardized tests. It is mainly used for disease diagnosis, condition monitoring and efficacy evaluation. Its core functions include: early screening of respiratory diseases (such as COPD, asthma), identification of causes of dyspnea, assessment of surgical tolerance and occupational disease protection effects. The examination items mainly focus on vital capacity, airway resistance, and diffusing function, supplemented by special tests such as bronchial provocation test, to provide objective data support for clinical practice.

Core tools for diagnosis and differential diagnosis

Pulmonary function tests can accurately differentiate between obstructive (such as asthma) and restrictive (such as pulmonary fibrosis) lung diseases. PassFEV1/FVC ratioCan determine the degree of airway obstruction, andtotal lung capacity (TLC)The measurement can identify lung volume limitations. For example, if a patient with chronic cough has a positive bronchodilation test, asthma can be diagnosed; regular testing of workers with pneumoconiosis can detect early decline in lung function. This examination makes up for the defect that imaging cannot evaluate function and has become an indispensable "functional microscope" in the respiratory department.

Applications for disease management and treatment monitoring

Dynamic tracking of lung function changes can objectively evaluate treatment effects. For patients with asthma, an improvement in FEV1 of ≥12% after taking medication is considered the drug is effective. For patients with COPD, a decrease in FEV1 of ≥40ml per year indicates an acceleration of the disease. Clinical studies show that standardized monitoring can reduce the acute exacerbation rate of COPD by 23% (GOLD 2023 Guide). For interstitial lung disease,DLCO (diffusion function)Numerical values can predict survival better than CT and are the key basis for formulating treatment plans.

Preoperative risk assessment and health management

Pulmonary function assessment must be performed before major thoracic and abdominal surgery.FEV1＜1LThe risk of postoperative complications increases fourfold. Patients undergoing lung volume reduction surgery need to meet the surgical indications of RV/TLC >60%. In addition, this examination is also used in health management scenarios such as athlete respiratory function assessment and altitude work adaptability test. In the field of occupational disease prevention and control, occupational lung diseases such as silicosis can be detected early through regular testing and secondary prevention can be achieved.

Technology development and multi-dimensional value

With the popularity of portable pulmonary function meters (such as COPD-6 screening machines), examinations have moved from tertiary hospitals to the community. Mainstream equipment manufacturers include GermanyJaeger(MasterScreen series), United StatesCareFusion(Vmax series) etc. It is worth noting that pulmonary function tests need to be comprehensively judged in conjunction with medical history and other tests. The normal values ​​are affected by age, gender, and race. As the "gold standard" for respiratory disease management, this technology will continue to provide core parameter support for personalized medicine.

Data source: Pulmonary Function Test Guidelines of the Respiratory Disease Branch of the Chinese Medical Association, American Thoracic Society (ATS) Technical Standards